On the 18th, Novo Nordisk announced that it has appointed Sasha Semienchuk as the VP and General Manager of its Korean subsidiary effective in October.

Sasha Semienchuk owns over 20 years of experience in healthcare across sales, marketing, research, and management at multinational pharmaceutical companies and startups in 7 countries on three continents.

After joining Novo Nordisk in 2012, Semienchuk was engaged in various diseases and therapeutic areas. From 2015, Semienchuk served as a Senior Director of Global Marketing in the obesity disease area at Novo Nordisk in Denmark and led communication and commercial activity between global exepert organizations.